Regulatory · source year

2003 regulatory records

5 selected, source-linked regulatory records dated 2003. This is selective source coverage, not a complete timeline.

Dated records

5 selected records.

Peptide profiles

6 connected profiles.

Cited sources

5 distinct public records.

Cited chronology

Dated source records

All record types in 2003 →

September 2003

1 record

August 2003

1 record

Histrelin + 1 more

Federal Register notice 03-20949

The Federal Register published notice 03-20949, attributed to FDA and its parent HHS department, on 2003-08-18. Its official title is “Eli Lilly and Co. et al.; Withdrawal of Approval of 80 New Drug Applications and 75 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Histrelin and Secretin.

Source: Federal Register via GovInfo ↗

→

June 2003

1 record

Oxytocin

Federal Register rule 03-15618

The Federal Register published rule 03-15618, attributed to FDA and its parent HHS department, on 2003-06-20. Its official title is “Dosage Form New Animal Drugs; Change of Sponsor; Technical Amendment,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.

Source: Federal Register via GovInfo ↗

→

March 2003

1 record

February 2003

1 record